A HOTAIR regulatory element modulates glioma cell sensitivity to temozolomide through long-range regulation of

Lei Zhang1, Anshun He1, Bohan Chen1

  • 1State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Nankai University, 300071, Tianjin, China.

Genome Research
|January 19, 2020
PubMed

Insights

Deleting a HOTAIR regulatory element enhances glioma sensitivity to temozolomide (TMZ) chemotherapy. This finding reveals new therapeutic targets, CALCOCO1 and ZC3H10, for improving patient outcomes in glioma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Temozolomide (TMZ) is a standard chemotherapy for glioma.
  • Chemoresistance to TMZ significantly limits its therapeutic efficacy.
  • Understanding resistance mechanisms is crucial for improving glioma patient prognosis.

Purpose of the Study:

  • To investigate the role of the HOTAIR regulatory element in glioma chemoresistance.
  • To identify genes regulated by HOTAIR that influence TMZ sensitivity.
  • To elucidate a novel regulatory mechanism for TMZ sensitivity in glioma.

Main Methods:

  • RNA sequencing (RNA-seq) to analyze gene expression changes.
  • Capture Hi-C to identify regulatory element interactions.
  • Analysis of patient survival data.
  • Rescue experiments and 3C technology for validation.

Main Results:

  • Deletion of a HOTAIR regulatory element increased glioma cell sensitivity to TMZ.
  • This deletion altered the transcription of multiple genes.
  • CALCOCO1 and ZC3H10 were identified as target genes repressed by the HOTAIR element.
  • Both CALCOCO1 and ZC3H10 were found to regulate TMZ sensitivity.

Conclusions:

  • A novel regulatory mechanism involving a HOTAIR element controlling CALCOCO1 and ZC3H10 impacts glioma cell TMZ sensitivity.
  • Targeting this mechanism offers a potential strategy to overcome TMZ resistance.
  • This research provides new insights into glioma treatment and patient prognosis.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K